Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1967 Aug;46(8):1338–1345. doi: 10.1172/JCI105626

Impaired Lymphocyte Transformation and Delayed Hypersensitivity in Sjögren's Syndrome*

Brigid G Leventhal 1,, Donald S Waldorf 1,, Norman Talal 1
PMCID: PMC297135  PMID: 16695922

Abstract

In vitro lymphocyte transformation in response to phytohemagglutinin and streptolysin O and in vivo skin sensitization to 2,4-dinitrochloro-benzene has been studied in patients with Sjögren's syndrome and in normal controls of comparable age and sex. Both the in vivo and in vitro responses were significantly impaired in the Sjögren's patients as compared to the controls. This lack of response to mitogenic agents is probably due to an intrinsic defect in the lymphocytes rather than to a serum factor. The abnormalities were less marked in patients whose disease was localized to the parotid and lacrimal glands than in those with generalized disease, i.e., with complicating rheumatoid arthritis or pseudolymphoma.

Full text

PDF
1338

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERNIER J. L., BHASKAR S. N. Lymphoepithelial lesions of salivary glands; histogenesis and classification based on 186 cases. Cancer. 1958 Nov-Dec;11(6):1156–1179. doi: 10.1002/1097-0142(195811/12)11:6<1156::aid-cncr2820110611>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  2. BLOCH K. J., BUCHANAN W. W., WOHL M. J., BUNIM J. J. SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) 1965 May;44:187–231. [PubMed] [Google Scholar]
  3. Chase M. W. Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis. Cancer Res. 1966 Jun;26(6):1097–1120. [PubMed] [Google Scholar]
  4. GODWIN J. T. Benign lymphoepithelial lesion of the parotid gland adenolymphoma, chronic inflammation, lymphoepithelioma, lymphocytic tumor, Mikulicz disease. Cancer. 1952 Nov;5(6):1089–1103. doi: 10.1002/1097-0142(195211)5:6<1089::aid-cncr2820050604>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  5. HIRSCHHORN K., SCHREIBMAN R. R., BACH F. H., SILTZBACH L. E. IN-VITRO STUDIES OF LYMPHOCYTES FROM PATIENTS WITH SARCOIDOSIS AND LYMPHOPROLIFERATIVE DISEASES. Lancet. 1964 Oct 17;2(7364):842–843. doi: 10.1016/s0140-6736(64)90691-9. [DOI] [PubMed] [Google Scholar]
  6. Hersh E. M., Oppenheim J. J. Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med. 1965 Nov 4;273(19):1006–1012. doi: 10.1056/NEJM196511042731903. [DOI] [PubMed] [Google Scholar]
  7. Hornbaker J. H., Jr, Foster E. A., Williams G. S., Davis J. S. Sjögren's syndrome and nodular reticulum cell sarcoma. Arch Intern Med. 1966 Nov;118(5):449–452. [PubMed] [Google Scholar]
  8. Leikin S. L., Bazelon M., Park K. H. In vitro lymphocyte transformation in ataxia telangiectasia. J Pediatr. 1966 Mar;68(3):477–479. doi: 10.1016/s0022-3476(66)80255-x. [DOI] [PubMed] [Google Scholar]
  9. MACKINNEY A. A., Jr, STOHLMAN F., Jr, BRECHER G. The kinetics of cell proliferation in cultures of human peripheral blood. Blood. 1962 Mar;19:349–358. [PubMed] [Google Scholar]
  10. McIntyre O. R., Segel W. D. P.HA. and thymic lymphocytes. Lancet. 1966 Jun 4;1(7449):1265–1265. doi: 10.1016/s0140-6736(66)90278-9. [DOI] [PubMed] [Google Scholar]
  11. NOWELL P. C. Inhibition of human leukocyte mitosis by prednisolone in vitro. Cancer Res. 1961 Dec;21:1518–1521. [PubMed] [Google Scholar]
  12. NOWELL P. C. Phytohemagglutinin: an initiator of mitosis in cultures of normal human leukocytes. Cancer Res. 1960 May;20:462–466. [PubMed] [Google Scholar]
  13. OPPENHEIM J. J., WHANG J., FREI E., 3rd IMMUNOLOGIC AND CYTOGENETIC STUDIES OF CHRONIC LYMPHOCYTIC LEUKEMIC CELLS. Blood. 1965 Aug;26:121–132. [PubMed] [Google Scholar]
  14. Oppenheim J. J., Barlow M., Waldmann T. A., Block J. B. Impaired in vitro lymphocyte transformation in patients with ataxia-telangiectasis. Br Med J. 1966 Aug 6;2(5509):330–333. doi: 10.1136/bmj.2.5509.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Oppenheim J. J., Wolstencroft R. A., Gell P. G. Delayed hypersensitivity in the guinea-pig to a protein-hapten conjugate and its relationship to in vitro transformation of lymph node, spleen, thymus and peripheral blood lymphocytes. Immunology. 1967 Jan;12(1):89–102. [PMC free article] [PubMed] [Google Scholar]
  16. PEARMAIN G., LYCETTE R. R., FITZGERALD P. H. Tuberculin-induced mitosis in peripheral blood leucocytes. Lancet. 1963 Mar 23;1(7282):637–638. doi: 10.1016/s0140-6736(63)91275-3. [DOI] [PubMed] [Google Scholar]
  17. PETERSON R. D., COOPER M. D., GOOD R. A. THE PATHOGENESIS OF IMMUNOLOGIC DEFICIENCY DISEASES. Am J Med. 1965 Apr;38:579–604. doi: 10.1016/0002-9343(65)90135-x. [DOI] [PubMed] [Google Scholar]
  18. ROTHMAN S., BLOCK M., HAUSER F. V. Sjögren's syndrome associated with lymphoblastoma and hypersplenism. AMA Arch Derm Syphilol. 1951 May;63(5):642–643. [PubMed] [Google Scholar]
  19. Robbins J. H. Human peripheral blood in tissue culture and the action of phytohemagglutinin. Experientia. 1964 Mar 15;20(3):164–168. doi: 10.1007/BF02150714. [DOI] [PubMed] [Google Scholar]
  20. SCHREK R., RABINOWITZ Y. Effects of phytohemagglutinin on rat and normal and leukemic human blood cells. Proc Soc Exp Biol Med. 1963 May;113:191–194. doi: 10.3181/00379727-113-28317. [DOI] [PubMed] [Google Scholar]
  21. TALAL N., BUNIM J. J. THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME. Am J Med. 1964 Apr;36:529–540. doi: 10.1016/0002-9343(64)90101-9. [DOI] [PubMed] [Google Scholar]
  22. Talal N. Sjögren's syndrome. Bull Rheum Dis. 1966 Mar;16(7):404–407. [PubMed] [Google Scholar]
  23. Winkelstein A., Craddock C. G. Comparative response of normal human thymus and lymph node cells to phytohemagglutinin in culture. Blood. 1967 Apr;29(4 Suppl):594–607. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES